Anti‐MUC1 aptamer: A potential opportunity for cancer treatment
- 31 July 2017
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 37 (6), 1518-1539
- https://doi.org/10.1002/med.21462
Abstract
Mucin 1 (MUC1) is a protein usually found on the apical surface of most normal secretory epithelial cells. However, in most adenocarcinomas, MUC1 is overexpressed, so that it not only appears over the entire cell surface, but is also shed as MUC1 fragments into the blood stream. These phenomena pinpoint MUC1 as a potential target for the diagnosis and treatment of cancer; consequently, interest has increased in MUC1 as a molecular target for overcoming cancer therapy challenges. MUC1 currently ranks second among 75 antigen candidates for cancer vaccines, and different antibodies or aptamers against MUC1 protein are proving useful for tracing cancer cells in the emerging field of targeted delivery. The unique properties of MUC1 aptamers as novel targeting agents, and the revolutionary role that MUC1 now plays in cancer therapy, are the focus of this review. Recent advancements in MUC1-targeted cancer therapy are also assessed.Keywords
This publication has 83 references indexed in Scilit:
- Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In VitroPLOS ONE, 2012
- Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In VitroPLOS ONE, 2011
- Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancerJournal of Controlled Release, 2011
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transitionOncogene, 2010
- MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1Blood, 2009
- Intracellular MUC1 Peptides Inhibit Cancer ProgressionClinical Cancer Research, 2008
- Phototoxic aptamers selectively enter and kill epithelial cancer cellsNucleic Acids Research, 2008
- MUC1* Mediates the Growth of Human Pluripotent Stem CellsPLOS ONE, 2008
- Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete RemissionJournal of Clinical Oncology, 2006